Purchase Order 75D30123P17330

Award Date 9/27/23
Potential Completion Date 11/30/23
Potential Value $55K
Federal Agency
CDC Pittsburgh
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for GENEXPERT IV. The contract has a potential value of $118,086.25 and a completion date of October 4, 2019. As the original equipment manufacturer, Cepheid provides a range of goods and services related to diagnostic testing equipment, reagents, and consumables, as well as associated...
This is a federal purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, awarded on September 20, 2023, is for Cepheid's GeneXpert Standard Level Service, with a ceiling value of $135,274.55 and a performance period that extends through August 31, 2028. The contract is a firm fixed-price agreement and does not have a...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, valued at $119,399.40, is for the maintenance and service of Cepheid's GeneXpert GX4-4 and GX-16-16 instruments, including software updates and calibration cartridges, which are used to validate...
The Centers for Disease Control and Prevention (CDC) has awarded a one-year, $49,558.00 firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide maintenance services for three Cepheid GeneXpert Infinity laboratory instruments used in the CDC's laboratories in Atlanta, Georgia. The contract includes 24/7 phone support, onsite maintenance 5 days per week, annual preventative maintenance, and software upgrades. This is a...
This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a Delivery Order under Cepheid's existing General Services Administration (GSA) Schedule 66 contract for Scientific Equipment and Services, with a Firm Fixed Price pricing type. The award, valued at $148,585.00, is for the provision of CEPHEID GENEXPERT diagnostic products, including...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for yearly maintenance service on Cepheid GeneXpert instruments. The $43,950.00 contract has a completion date of September 29, 2029. Cepheid is the prime contractor and original equipment manufacturer, with no set-aside designation. The contract is part of Cepheid's broader work providing...
This is a $55,869.00 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the provision of CEMB CEPHEID MA and replacement computer equipment, with a period of performance through July 5, 2026. This award does not have a set-aside designation. Cepheid is an experienced federal contractor, holding multiple Indefinite Delivery...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $279,558.00 contract is for a GeneXpert service agreement to provide equipment, reagents, test kits, and maintenance services for molecular diagnostic testing capabilities, including for detecting infectious diseases such as COVID-19, influenza, and others. Cepheid holds several significant federal contract Indefinite Delivery Vehicles (IDVs)...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $149,435.00 contract is for the purchase of 16 GeneXpert XVI R@ 16 Module Systems to support the agency's Ebola response efforts. The award is not set-aside and represents a direct procurement from the original equipment manufacturer. Cepheid has been awarded multiple federal contracts...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $205,470.00 firm-fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, which is not set aside, is for the provision of reagents, test kits, instruments, and testing platforms to support the CDC's clinical diagnostic programs. Cepheid, as the prime contractor, has a...

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Cepheid a $55,135 purchase order contract to provide CEPHEID GENEXPERT equipment and services. Under this firm fixed price award, Cepheid will deliver its GeneXpert molecular diagnostic platform to support HHS-CDC programs in Chamblee, Georgia through November 2023. The GeneXpert system enables rapid on-site PCR testing and is a valuable tool for public health agencies. No subcontractors or set aside designations were identified. This purchase builds upon the CDC's established use of Cepheid's technology to advance infectious disease monitoring and response initiatives.

Generated 12/20/23, 4:33 AM